Market Overview:
The global surface protein gp120 market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of HIV/AIDS and rising demand for better treatment options. Based on type, the global surface protein gp120 market is segmented into DS-003, BMD-104, HNG-156, M-48U1 and others. DS-003 held the largest share of the global surface protein gp120 market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high efficacy and safety profile. Based on application, hospital held the largest share of the global surface protein gp120 market in 2017 and is expected to maintain its dominance duringthe forecast period.
Product Definition:
gp120 is a glycoprotein found on the surface of the human immunodeficiency virus (HIV). It is important for HIV to attach to and enter cells, where it can then replicate. Drugs that block gp120 may be used to treat or prevent HIV infection.
DS-003:
The drug-like substance (DS-003) is a new drug with an innovative mechanism of action. It has been designed to treat patients infected with the HIV virus, which cannot be treated by current anti-retroviral drugs. DS-003 is currently under phase II clinical trials and expected to be commercialized in 2015.
BMD-104:
BD Bioscience is a leading developer of monoclonal antibodies and offers a wide range of products for research, diagnostics, and therapeutic applications. The company’s expertise covers an extensive range of antibody therapeutics including tumor-antigen targeting, immuno-oncology, immunotherapy & autoimmune disease therapy.
Application Insights:
Based on application, the global market has been segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This is due to an increase in government funding for HIV/AIDS treatment coupled with rising awareness about the disease among individuals at high-risk. Moreover, a rise in new product approvals by prominent companies such as Merck & Co., Inc., Pfizer, Inc., and Johnson & Johnson is expected to drive demand over the forecast period.
The clinic segment was estimated to be worth USD 142 million in 2017 owing to an increase in spending on antiretroviral drugs that are used against AIDS infections among individuals who have sex with men as well as heterosexuals living with HIV infection without access to affordable treatment facilities or skilled personnel at low cost across major regions of the world including North America and Europe.
Regional Analysis:
North America dominated the global surface protein gp120 market in 2017. The presence of a large number of manufacturers and the introduction of novel products are some factors responsible for its largest share. In addition, increasing funding by government organizations is also expected to contribute towards regional growth over the forecast period. For instance, in March 2018, New York Blood Center announced about receiving a gift from Gilead Sciences Inc.
Asia Pacific is anticipated to grow at an exponential rate during the forecast period owing to various factors such as rising incidence of HIV/AIDS & cancer due to infection with surface protein gp120 variants coupled with growing R&D expenditure by pharmaceutical companies for developing new drugs targeting these proteins.
Growth Factors:
- Increasing HIV/AIDS prevalence rates across the globe is expected to drive demand for surface protein gp120 over the forecast period.
- Growing number of clinical trials for development of novel therapeutics is anticipated to propel market growth.
- Rising investments by key players in R&D activities is likely to provide impetus to the market growth.
- Technological advancements in detection and diagnosis of HIV infections are projected to boost demand for surface protein gp120 over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Surface Protein gp120 Market Research Report
By Type
DS-003, BMD-104, HNG-156, M-48U1, Others
By Application
Hospital, Clinic, Others
By Companies
GlaxoSmithKline Plc, Osel, Inc., Sanofi Pasteur SA, TeneoBio Inc, United Biomedical, Inc., ViiV Healthcare Limited, GlaxoSmithKline Plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Surface Protein gp120 Market Report Segments:
The global Surface Protein gp120 market is segmented on the basis of:
Types
DS-003, BMD-104, HNG-156, M-48U1, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline Plc
- Osel, Inc.
- Sanofi Pasteur SA
- TeneoBio Inc
- United Biomedical, Inc.
- ViiV Healthcare Limited
- GlaxoSmithKline Plc
Highlights of The Surface Protein gp120 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DS-003
- BMD-104
- HNG-156
- M-48U1
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Surface Protein gp120 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
gp120 is a protein that is found on the surface of HIV-1. It helps the virus attach to cells and spread through the body.
Some of the major players in the surface protein gp120 market are GlaxoSmithKline Plc, Osel, Inc., Sanofi Pasteur SA, TeneoBio Inc, United Biomedical, Inc., ViiV Healthcare Limited, GlaxoSmithKline Plc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surface Protein gp120 Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Surface Protein gp120 Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Surface Protein gp120 Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Surface Protein gp120 Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Surface Protein gp120 Market Size & Forecast, 2020-2028 4.5.1 Surface Protein gp120 Market Size and Y-o-Y Growth 4.5.2 Surface Protein gp120 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DS-003
5.2.2 BMD-104
5.2.3 HNG-156
5.2.4 M-48U1
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Surface Protein gp120 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Surface Protein gp120 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DS-003
9.6.2 BMD-104
9.6.3 HNG-156
9.6.4 M-48U1
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DS-003
10.6.2 BMD-104
10.6.3 HNG-156
10.6.4 M-48U1
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DS-003
11.6.2 BMD-104
11.6.3 HNG-156
11.6.4 M-48U1
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DS-003
12.6.2 BMD-104
12.6.3 HNG-156
12.6.4 M-48U1
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DS-003
13.6.2 BMD-104
13.6.3 HNG-156
13.6.4 M-48U1
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Surface Protein gp120 Market: Competitive Dashboard
14.2 Global Surface Protein gp120 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline Plc
14.3.2 Osel, Inc.
14.3.3 Sanofi Pasteur SA
14.3.4 TeneoBio Inc
14.3.5 United Biomedical, Inc.
14.3.6 ViiV Healthcare Limited
14.3.7 GlaxoSmithKline Plc